Suppr超能文献

通过人T细胞克隆鉴定蓖麻毒素A链HLA II类限制性表位

Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.

作者信息

Tommasi M, Castelletti D, Pasti M, Fracasso G, Lorenzetti I, Sartoris S, Pera C, Ferrara G B, Tridente G, Colombatti M

机构信息

Section of Immunology, Department of Pathology, University of Verona, Italy.

出版信息

Clin Exp Immunol. 2001 Sep;125(3):391-400. doi: 10.1046/j.1365-2249.2001.01525.x.

Abstract

The identification of ricin toxin A-chain (RTA) epitopes and the molecular context in which they are recognized will allow strategies to be devised that prevent/suppress an anti-RTA immune response in patients treated with RTA-based immunotoxins. RTA-specific human T-cell lines and T-cell clones were produced by in vitro priming of PBMC. The T-cell clones used a limited set of Vbeta chains (Vbeta1, Vbeta2 and Vbeta8) to recognize RTA epitopes. The use of RTA deletion mutants demonstrated that T-cell lines and T-cell clones from three out of four donors responded to RTA epitopes within the domain D124-Q223, whereas one donor recognized the region I1-D124. The response to RTA peptides of T-cell lines and T-cell clones from two donors allowed the identification of immunogenic segments (D124-G140 and L161-T190) recognized in the context of different HLA-DRB1 alleles (HLA-DRB10801, and HLA-DRB111011 and B103011, respectively). The response to L161-T190 was investigated in greater detail. We found that the HLA-DRB103011 allele presents a minimal epitope represented by the sequence I175-Y183 of RTA, whereas the HLA-DRB111011 allele presents the minimal epitope M174-I184. RTA peptides and an I175A RTA point mutant allowed us to identify I175 as a crucial residue for the epitope(s) recognized by the two HLA-DRB1 alleles. Failure of T-cell clones to recognize ribosome inactivating proteins (RIPs) showing sequences similar but not identical to RTA further confirmed the role of I175 as a key residue for the epitope recognized in the context of HLA-DRB111011/03011 alleles.

摘要

鉴定蓖麻毒素A链(RTA)表位及其被识别的分子环境,将有助于设计出相关策略,以预防/抑制接受基于RTA的免疫毒素治疗的患者产生抗RTA免疫反应。通过体外刺激外周血单核细胞(PBMC)产生了RTA特异性人T细胞系和T细胞克隆。这些T细胞克隆使用有限的一组Vβ链(Vβ1、Vβ2和Vβ8)来识别RTA表位。使用RTA缺失突变体表明,来自四个供体中的三个供体的T细胞系和T细胞克隆对结构域D124-Q223内的RTA表位有反应,而一个供体识别区域I1-D124。来自两个供体的T细胞系和T细胞克隆对RTA肽的反应,使得能够鉴定在不同HLA-DRB1等位基因(分别为HLA-DRB10801、HLA-DRB111011和B103011)背景下被识别的免疫原性片段(D124-G140和L161-T190)。对L161-T190的反应进行了更详细的研究。我们发现,HLA-DRB103011等位基因呈现出一个由RTA的I175-Y183序列代表的最小表位,而HLA-DRB111011等位基因呈现出最小表位M174-I184。RTA肽和一个I175A RTA点突变体使我们能够确定I175是这两个HLA-DRB1等位基因识别的表位的关键残基。T细胞克隆无法识别显示与RTA序列相似但不完全相同的核糖体失活蛋白(RIP),这进一步证实了I175作为在HLA-DRB111011/03011等位基因背景下被识别的表位的关键残基的作用。

相似文献

1
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.
Clin Exp Immunol. 2001 Sep;125(3):391-400. doi: 10.1046/j.1365-2249.2001.01525.x.
2
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response.
Int Immunol. 2005 Apr;17(4):365-72. doi: 10.1093/intimm/dxh216. Epub 2005 Feb 21.
4
Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
Eur J Immunol. 1998 Jan;28(1):305-16. doi: 10.1002/(SICI)1521-4141(199801)28:01<305::AID-IMMU305>3.0.CO;2-3.
6
Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
Transplantation. 1996 Nov 15;62(9):1332-40. doi: 10.1097/00007890-199611150-00027.

引用本文的文献

1
Toxicity and Efficacy Evaluation of Soluble Recombinant Ricin Vaccine.
Vaccines (Basel). 2024 Sep 29;12(10):1116. doi: 10.3390/vaccines12101116.
2
Strong protection against ricin challenge induced by a novel modified ricin A-chain protein in mouse model.
Hum Vaccin Immunother. 2015;11(7):1779-87. doi: 10.1080/21645515.2015.1038446.
3
Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.
Clin Vaccine Immunol. 2012 Oct;19(10):1697-9. doi: 10.1128/CVI.00381-12. Epub 2012 Aug 22.
5
Ribosome depurination is not sufficient for ricin-mediated cell death in Saccharomyces cerevisiae.
Infect Immun. 2007 Jan;75(1):417-28. doi: 10.1128/IAI.01295-06. Epub 2006 Nov 13.
6
A pilot clinical trial of a recombinant ricin vaccine in normal humans.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2268-73. doi: 10.1073/pnas.0510893103. Epub 2006 Feb 3.

本文引用的文献

1
IMGT/HLA database--a sequence database for the human major histocompatibility complex.
Tissue Antigens. 2000 Mar;55(3):280-7. doi: 10.1034/j.1399-0039.2000.550314.x.
2
Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis.
Immunol Rev. 1999 Jun;169:123-37. doi: 10.1111/j.1600-065x.1999.tb01311.x.
4
Clinical trials with blocked ricin immunotoxins.
Curr Top Microbiol Immunol. 1998;234:35-56. doi: 10.1007/978-3-642-72153-3_3.
8
Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin.
Ann Intern Med. 1997 Jun 1;126(11):882-5. doi: 10.7326/0003-4819-126-11-199706010-00005.
10
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas.
Tissue Antigens. 1996 Oct;48(4 Pt 1):301-11. doi: 10.1111/j.1399-0039.1996.tb02649.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验